• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Copegus (ribavirin) tablet

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – March 2010


Summary View



Postmarketing Experience
  • Additionally, pure red cell aplasia (PRCA) has been reported with Copegus in combination with Pegasys.